Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
17.11
+1.53 (9.82%)
Oct 15, 2025, 4:00 PM EDT - Market closed
Adaptive Biotechnologies Revenue
Adaptive Biotechnologies had revenue of $58.88M in the quarter ending June 30, 2025, with 36.33% growth. This brings the company's revenue in the last twelve months to $205.22M, up 21.60% year-over-year. In the year 2024, Adaptive Biotechnologies had annual revenue of $178.96M with 5.10% growth.
Revenue (ttm)
$205.22M
Revenue Growth
+21.60%
P/S Ratio
12.43
Revenue / Employee
$331,528
Employees
619
Market Cap
2.61B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 178.96M | 8.68M | 5.10% |
Dec 31, 2023 | 170.28M | -15.03M | -8.11% |
Dec 31, 2022 | 185.31M | 30.96M | 20.06% |
Dec 31, 2021 | 154.34M | 55.96M | 56.88% |
Dec 31, 2020 | 98.38M | 13.31M | 15.65% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 92.15B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
ADPT News
- 13 hours ago - Adaptive Biotechnologies to Report Third Quarter 2025 Financial Results on November 5, 2025 - GlobeNewsWire
- 5 weeks ago - Adaptive Biotechnologies Corporation (ADPT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 7 weeks ago - Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Aristotle Focus Growth Q2 Highlights: Top Performers, Surprises And Strategic Shifts - Seeking Alpha
- 2 months ago - Adaptive Biotechnologies Corporation (ADPT) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Adaptive Biotechnologies Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - Adaptive Biotechnologies to Report Second Quarter 2025 Financial Results on August 5, 2025 - GlobeNewsWire
- 3 months ago - Adaptive Biotechnologies and Flatiron Health Announce Integration of clonoSEQ® MRD Testing into OncoEMR® - GlobeNewsWire